The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: Results from a pivotal phase III study

1. Cano, A.
2. Estévez, J.
3. Usandizaga, R.
4. Gallo, J.L.
5. Guinot, M.
6. Delgado, J.L.
7. Castellanos, E.
8. Moral, E.
9. Nieto, C.
10. Del Prado, J.M.
11. Ferrer, J.